Kaytser Victor, Zhang Pengfei
Department of Neurology, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States.
Front Neurol. 2021 Feb 17;12:632830. doi: 10.3389/fneur.2021.632830. eCollection 2021.
Polypharmacy in abortive medications is often inevitable for patients with refractory headaches. We seek to enumerate an exhaustive list of headaches abortive medications that are without drug-drug interactions. We updated a list of acute medications based on the widely used Jefferson Headache Manual with novel abortive medications including ubrogepant, lasmiditan, and rimegepant. Opioids and barbiturate-containing products are excluded. From this resultant list of medications, we then conducted an exhaustive search of all pair-wise interactions via DrugBank's API. Using this interaction list, we filtered all possible two, three, and four drug combinations of abortive medications. The list of medications was then reapplied to DrugBank to verify the lack of known drug-drug interactions. There are 192 medication combinations that do not contain any drug-drug interactions. Most common elements in these combinations are ubrogepant, prochlorperazine, followed by tizanidine. There are 67 three-drug combinations that do not contain interactions. Only two of the four-drug combinations do not yield some form of drug-drug interactions. This list of headaches abortive medications without drug-drug interactions is a useful tool for clinicians seeking to more effectively manage refractory headaches by implementing a rational polypharmacy.
对于难治性头痛患者而言,使用多种药物进行头痛发作期治疗往往不可避免。我们试图列出一份详尽的无药物相互作用的头痛发作期治疗药物清单。我们根据广泛使用的《杰斐逊头痛手册》更新了急性药物清单,纳入了新型的头痛发作期治疗药物,如ubrogepant、拉米地坦和利美尼坦。阿片类药物和含巴比妥酸盐的产品被排除在外。然后,我们通过DrugBank的应用程序编程接口(API)对这份最终的药物清单进行了所有两两相互作用的详尽搜索。利用这份相互作用清单,我们筛选出了所有可能的两种、三种和四种头痛发作期治疗药物的组合。之后,我们再次将这份药物清单应用于DrugBank,以验证不存在已知的药物相互作用。共有192种药物组合不存在任何药物相互作用。这些组合中最常见的成分是ubrogepant、丙氯拉嗪,其次是替扎尼定。有67种三种药物的组合不存在相互作用。四种药物的组合中只有两种不会产生某种形式的药物相互作用。这份无药物相互作用的头痛发作期治疗药物清单是临床医生的一个有用工具,有助于他们通过合理使用多种药物更有效地治疗难治性头痛。